Brucellosis: A Retrospective Sero-epidemiological Study

Main Article Content

Ali Dahmani
Nadjet Amina Khelifi-Touhami
Manal Khelifi-Touhami Khelifi-Touhami
Nassim Ouchene

Abstract

Introduction: Brucellosis is one of the most important worldwide zoonotic diseases caused by the bacterial genus Brucella. It is frequently misdiagnosed and can therefore lead to inappropriate treatment and prolonged disease. This study aimed to investigate the seroprevalence of human brucellosis cases and compare it with the national average and the number of goat brucellosis cases in Algeria.


Materials and methods: A total of 3223 patients suspected of brucellosis were collected during 2008-2015 in Djelfa, central Algeria. Rose Bengal test and Wright's serum agglutination were used for the diagnosis.


Results: The number of positive cases was 1281 (39.74%), including 743 (58.04%) men and 537 (41.96%) women, resulting in a ratio of 1.38. Men were infected more than women. The number of positive cases was observed frequently between April and September. However, there was no significant difference among the investigated years in terms of infection. The highest prevalence was observed in individuals aged between 11 and 30 years (21.62-22.32%). The seroprevalence of human brucellosis in the current study in Djelfa was significantly higher, compared to the national level. The number of animals (goats) and human cases reported at the national level and Djelfa followed a similar trend.


Conclusion: Brucellosis still remains a serious public health threat in the study area. Epidemiological surveillance of brucellosis should be considered a priority in order to reduce the prevalence of human and animal brucellosis.

Article Details

How to Cite
Dahmani, A., Khelifi-Touhami, N. A., Khelifi-Touhami, M. K.-T., & Ouchene, N. (2022). Brucellosis: A Retrospective Sero-epidemiological Study. Journal of Veterinary Physiology and Pathology, 1(2), 43–48. https://doi.org/10.58803/jvpp.v1i2.1
Section
Original Articles

References

Behera SK, Das D, Balasubramani K, Chellappan S, Rajaram K, Mohanta HK, Balabaskaran Nina P. Seroprevalence and risk factors of brucellosis in livestock in the wildlife and livestock interface area of Similipal Biosphere Reserve, India, Vet World. 2020; 13(3): 465-470. DOI: http://doi.org/10.14202/vetworld.2020.465-470

Yanti Y, Sumiarto B, Kusumastuti TA, Panus A, Sodirun S.Seroprevalence and risk factors of brucellosis and the brucellosis model at the individual level of dairy cattle in the West Bandung District, Indonesia. Vet World. 2021; 14(1): 1-10. DOI: http://doi.org/10.14202/vetworld.2021.1-10

Diaz R, Casanova A, Ariza J, Moriyón I. The Rose Bengal Test in Human Brucellosis: A Neglected Test for the Diagnosis of a Neglected Disease. PLoS Neglect Trop Dis. 2011 ; 5(4): e950. DOI: https://doi.org/10.1371/journal.pntd.0000950

Ebid M, El Molla A, Salib F. Seroprevalence of brucellosis in sheep and goats in the Arabian Gulf region. Vet World. 2020; 13(8): 1495-1509. DOI: https://doi.org/10.14202/vetworld.2020.1495-1509

Hassan H, Salami A, Nehme N, Hakeem RA, EL Hage J, Awada R. Prevalence and prevention of brucellosis in cattle in Lebanon. Vet World. 2020; 13(2): 364-371. DOI: https://doi.org/10.14202/vetworld.2020.364-371

Aggad H, Boukraa L. Prevalence of bovine and human brucellosis in western Algeria: comparison of screening tests. East. Mediterr Health J. 2006; 12 (‎1-2): 119-128. Available at: https://apps.who.int/iris/handle/10665/117061

Whatmore Adrian, M. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infect Genet Evol. 2009; 9: 1168-1184. DOI: https://doi.org/10.1016/j.meegid.2009.07.001

WHO guidance Geneva (World Health Organization). Brucellosis in humans and animals. Saudi Med J. 2005; 20 (4): 311-315.

Thakur SD, Kumar R, Thapliyal DC. Human brucellosis: review of an under-diagnosed animal. J Communic Dis. 2002; 34 (4): 287-301. Available at: https://pubmed.ncbi.nlm.nih.gov/14710861

Troy SB, Rickman LS, Davis CE. Brucellosis in San Diego: epidemiology and species-related differences in acute clinical presentations. Medicine (Baltimore). 2005; 84(3): 174-187. DOI: https://doi.org/10.1097/01.md.0000165659.20988.25

Lounes N, Cherfa M A, Le Carrou G, Bouyoucef A, Jay M, Garin-Bastuji B, Mick V. Human brucellosis in Maghreb: existence of a lineage related to socio-historical connections with Europe. PLoS One. 2014; 9(12): e115319. DOI: http://doi.org/10.1371/journal.pone.0115319

Kardjadj M. The Epidemiology of Human and Animal Brucellosis in Algeria. J Bact Mycol. 2016; 3(2): 1025. Available at: https://austinpublishinggroup.com/bacteriology/fulltext/bacteriology-v3-id1025.php

Habib N, Regagba Z, Miara MD, Hammou MA, Snorek J. Floristic diversity of steppe vegetation in the region of Djelfa, North-West Algeria. Acta Botanica Malacitana, 2020; 45, 37-46. DOI: http://dx.doi.org/10.24310/abm.v45i0.7987

National Institute of Public Health. Annual epidemiological data 2008-2015, 2015. Algeria.

Pelerito A, Cordeiro R, Matos R, Santos MA, Soeiro S, Santos J, Manita C, Rio C, Santo M, Paixão E, Nunes A, Nuncio S. Human brucellosis in Portugal—Retrospective analysis of suspected clinical cases of infection from 2009 to 2016. PLoS One. 2017; 12(7): e0179667. DOI: https://doi.org/10.1371/journal.pone.0179667

Amro A, Mansoor B, Hamarsheh O, Hjaija D. Recent trends in human brucellosis in the West Bank, Palestine. Int J Infect Dis. 2021; 106, 308-313. DOI: https://doi.org/10.1016/j.ijid.2021.04.037

Minas M, Minas A, Gourgulianis K, Stournara A. Epidemiological and clinical aspects of human brucellosis in Central Greece. Jap J Infect Dis. 2007; 60(6): 362-366. Available at: https://www.niid.go.jp/niid/images/JJID/60/362.pdf

De Massis F, Di Girolamo A, Petrini A. Correlation between animal and human brucellosis in Italy during the period 1997–2002. Clin

Microbiol Infect. 2005; 11 (8): 632-636. DOI: https://doi.org/10.1111/j.1469-0691.2005.01204.x

Aloufi AD, Memish ZA, Assiri AM, Mcnabb SJN. Trends of reported human cases of brucellosis, Kingdom of Saudi Arabia, 2004-2012. J Epidemiol Glob Health. 2015; 6(1), 11-18. DOI: https://doi.org/10.1016/j.jegh.2015.09.001

Corbel MJ. Brucellosis in humans and animals. World Health Organization. 2006; p. 89.

Akoko JM, Pelle R, Lukambagire AS, Machuka EM, Nthiwa D, Mathew C, Fèvre EM, Bett B, Cook EAJ, Othero D, Bonfoh B, Kazwala RR, Shirima G, Schelling E, Halliday JB, Ouma, C. Molecular epidemiology of Brucella species in mixed livestock-human ecosystems in Kenya. Sci Rep. 2021; 11(1): 1-11. DOI: https://doi.org/10.1038/s41598-021-88327-z

Hizel K, Guzel O, Dizbay M, Karakus R, Senol E, Arman D, Aktas F, Ulutan F. Age and duration of disease as factors affecting clinical findings and sacroiliitis in brucellosis. Infection. 2007; 35: 434-437. DOI: https://doi.org/10.1007/s15010-007-6361-z

Migisha R, Nyehangane D, Boum Y, Page AL, Zúñiga-Ripa A, Conde-Álvarez R. Bonnet M. Prevalence and risk factors of brucellosis among febrile patients attending a community hospital in south western Uganda. Sci Rep. 2018; 8(1): 1-8. DOI: http://doi.org.10.1038/s41598-018-33915-9

Memish Z, Mah MW, Al Mahmoud S, Al Shaalan M, Khan MY. Brucella bacteraemia: clinical and laboratory observations in 160 patients. J. Infect. 2000; 40: 59-63. DOI: https://doi.org/10.1053/jinf.1999.0586

Navarro-Martinez A, Solera J, Corredoira J, Beato JL, Alfaro EM, Atiénzar M, Ariza J. Epididymoorchitis due to Brucellamellitensis: a retrospective study of 59 patients. Clin Infect Dis. 2001; 33(12): 2017-2022. DOI: https://doi.org/10.1086/324489

Alkahtani AM., Assiry MM, Chandramoorthy HC, Al-Hakami AM, Hamid ME. Sero-prevalence and risk factors of brucellosis among suspected febrile patients attending a referral hospital in southern Saudi Arabia (2014–2018). BMC Infect Dis. 2020; 20(1): 1-8. DOI: https://doi.org/10.1186/s12879-020-4763-z

Assafi M, Al-Berfkani MI. The seroprevalence of human brucellosis in different age groups patients and other associated risk factors in Duhok, Iraq. Innovaciencia. 2019; 7, 1–7. DOI: https://doi.org/10.15649/2346075X.2563

Muloki HN, Erume J, Owiny DO, Kungu JM, Nakavuma J, Ogeng D, Nasinyama GW. Prevalence and risk factors for brucellosis in prolonged fever patients in post-conflict Northern Uganda. Afr Health Sci. 2018; 18(1), 22-28. DOI: https://dx.doi.org/10.4314%2Fahs.v18i1.4

Akhvlediani T, Clark DV, Chubabria G, Zenaishvili O, Hepburn MJ. The changing pattern of human brucellosis: clinical manifestations, epidemiology, and treatment outcomes over three decades in Georgia. BMC Infect Dis. 2010; 10: 346-354. DOI: https://doi.org/10.1186/1471-2334-10-346.

Mantur BG, Biradar MS, Bidri RC, Mulimani MS, Veerappa K, Kariholu PJ, Patil SB, Mangalgi SS. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years’ experience in an endemic area. J Med Microbiol. 2006; 55: 897-903. DOI: https://doi.org/10.1099/jmm.0.46097-0